Business Description
Vivanza Biosciences Ltd
ISIN : INE984E01035
Total Employee Number:
8Compare
Compare
Traded in other countries / regions
530057.India IPO Date
1995-05-10Description
Vivanza Biosciences Ltd is a pharmaceutical company. Its core focus areas include research and development, manufacturing, and the distribution of a wide range of pharma and pharmaceutical products. The company's product portfolio includes Medical examination gloves, Injections, Veterinary feeds, and others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | 0.2 | |||||
Debt-to-Equity | 2.34 | |||||
Debt-to-EBITDA | 12.07 | |||||
Interest Coverage | 2.55 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 5.74 | |||||
Beneish M-Score | 13.1 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 87.6 | |||||
3-Year EBITDA Growth Rate | -9 | |||||
3-Year EPS without NRI Growth Rate | -59.5 | |||||
3-Year FCF Growth Rate | -42.6 | |||||
3-Year Book Growth Rate | 2.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 42.18 | |||||
9-Day RSI | 46.98 | |||||
14-Day RSI | 48.34 | |||||
3-1 Month Momentum % | -12.08 | |||||
6-1 Month Momentum % | -11.65 | |||||
12-1 Month Momentum % | -10.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.13 | |||||
Quick Ratio | 0.92 | |||||
Days Inventory | 11.37 | |||||
Days Sales Outstanding | 57.86 | |||||
Days Payable | 46.33 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 1.28 | |||||
Operating Margin % | 0.61 | |||||
Net Margin % | 0.34 | |||||
EBITDA Margin % | 0.73 | |||||
FCF Margin % | -2.33 | |||||
OCF Margin % | -2.23 | |||||
ROE % | 9.15 | |||||
ROA % | 1.34 | |||||
ROIC % | 3.53 | |||||
3-Year ROIIC % | -4.48 | |||||
ROC (Joel Greenblatt) % | 9.4 | |||||
ROCE % | 11.89 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 18.79 | |||||
PE Ratio without NRI | 18.79 | |||||
Shiller PE Ratio | 34.61 | |||||
PS Ratio | 0.06 | |||||
PB Ratio | 1.72 | |||||
Price-to-Tangible-Book | 2.71 | |||||
EV-to-EBIT | 21.25 | |||||
EV-to-EBITDA | 20.72 | |||||
EV-to-Revenue | 0.15 | |||||
EV-to-FCF | -6.53 | |||||
Price-to-GF-Value | 0.07 | |||||
Price-to-Projected-FCF | 1.1 | |||||
Price-to-Graham-Number | 1.48 | |||||
| Price-to-Net-Current-Asset-Value | 5.58 | |||||
Earnings Yield (Greenblatt) % | 4.7 | |||||
FCF Yield % | -36.73 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vivanza Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,159.106 | ||
| EPS (TTM) (₹) | 0.1 | ||
| Beta | 0.7788 | ||
| 3-Year Sharpe Ratio | -0.65 | ||
| 3-Year Sortino Ratio | -0.93 | ||
| Volatility % | 32.7 | ||
| 14-Day RSI | 48.34 | ||
| 14-Day ATR (₹) | 0.104838 | ||
| 20-Day SMA (₹) | 1.857 | ||
| 12-1 Month Momentum % | -10.78 | ||
| 52-Week Range (₹) | 1.52 - 2.72 | ||
| Shares Outstanding (Mil) | 40 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vivanza Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vivanza Biosciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| 10:1 Stock Split | 2023-03-24 | 19.75 (+0.00%) |
Show
Entries
Vivanza Biosciences Ltd Frequently Asked Questions
What is Vivanza Biosciences Ltd(BOM:530057)'s stock price today?
The current price of BOM:530057 is ₹1.84. The 52 week high of BOM:530057 is ₹2.72 and 52 week low is ₹1.52.
When is next earnings date of Vivanza Biosciences Ltd(BOM:530057)?
The next earnings date of Vivanza Biosciences Ltd(BOM:530057) is .
Does Vivanza Biosciences Ltd(BOM:530057) pay dividends? If so, how much?
Vivanza Biosciences Ltd(BOM:530057) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Vivanza Biosciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers